Atalante自平衡外骨骼作为完全性截瘫辅助移动设备的多维评估
结果显示Atalante外骨骼安全性和可行性可接受,穿戴时间随训练显著缩短,但严重骨质疏松被识别为关键风险因素,支持系统化骨密度筛查和谨慎排除标准。
要点
- Atalante外骨骼在监督下临床环境中对完全性截瘫患者安全可行,支持无手扶室内直立行走
- 穿戴时间从首次790秒降至末次223秒,脱下时间从242秒降至55秒,分别在第14和18次训练后趋于稳定
- 严重骨质疏松(髋部T值-3.8)患者发生胫骨平台骨折,提示需系统骨密度筛查和谨慎排除
核心结论
- 在监督下临床条件下,Atalante外骨骼作为完全性截瘫患者的辅助移动设备表现出可接受的安全性和可行性。
- 严重骨质疏松是外骨骼训练的关键风险因素,支持系统化骨密度检测和谨慎的排除标准。
- 研究结果支持将自平衡外骨骼整合入补偿性康复项目,并值得在生态环境中进一步研究真实世界自主性和参与结局。
研究设计与样本
- 前瞻性、单中心、纵向研究,纳入慢性完全性胸段脊髓损伤成人(AIS A级,神经平面T6-T12)。
- 结局从安全、技术功能可用性和可接受性三个维度评估,并用外骨骼辅助6分钟步行测试评估生理反应。
主要发现
- 发生1例严重不良事件:严重骨质疏松(髋部T值-3.8)参与者胫骨平台骨折并退出研究;无其他严重医学不良事件。
- 651次训练中记录4次近跌倒事件(占0.61%的训练次数,每步行10米为0.16%);轻微不良事件为一过性,无有症状体位性低血压报告。
- 项目中段与末次评估间,耗氧量、步行速度和运输成本保持稳定(p > 0.05),而感知用力显著下降(p = 0.003)。
- 穿戴时间从首次790 [475-966]秒降至末次223 [159-259]秒,脱下时间从242 [152-275]秒降至55 [50-69]秒,熟悉平台期分别出现在第14和18次训练后。
- 束带舒适度随时间改善,感知安全性总体稳定,但在易跌倒步态事件或技术脱开后有短暂下降。
关键数值与推荐
- 纳入标准为慢性完全性胸段脊髓损伤成人,AIS A级,神经平面T6-T12。
- 干预方案为6周内60次监督下外骨骼辅助训练,每次含40米步行。
- 近跌倒事件率为0.61%(按训练次数)和0.16%(每步行10米)。
- 感知用力在项目中段与末次评估间显著下降(p = 0.003);耗氧量、步行速度和运输成本无显著变化(p > 0.05)。
- 穿戴和脱下时间的熟悉平台期分别出现在第14和18次训练后。
临床怎么用
- 对完全性截瘫患者使用自平衡外骨骼前,应进行系统骨密度检测,严重骨质疏松者需谨慎评估或排除。
- 训练初期应关注穿戴和脱下时间较长的问题,预期约14至18次训练后操作效率趋于稳定。
- 在监督下临床环境中,外骨骼辅助步行代谢需求低,感知用力随训练下降,可作为补偿性康复项目的组成部分。
局限性
- 试验注册为回顾性注册(NCT06941896)。
- 研究未在生态环境中评估真实世界自主性和参与结局,作者建议进一步开展此类研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic exoskeletons are increasingly used in neurorehabilitation, yet evidence remains limited regarding their role as assistive locomotion devices within a compensatory rehabilitation framework, particularly in individuals with complete spinal cord injury. Multidimensional evaluations integrating safety, usability, and patient-reported experience are still scarce. OBJECTIVE: To evaluate the Atalante self-balancing exoskeleton as an assistive locomotion device in individuals with complete paraplegia through a multidimensional analysis conducted in a controlled clinical environment. METHODS: This prospective, monocentric, longitudinal study included adults with chronic complete thoracic spinal cord injury (American Spinal Injury Association Impairment Scale grade A, neurological level T6-T12). Participants underwent an intensive 6-week program comprising 60 supervised sessions of exoskeleton-assisted training including 40 m walking per session. Outcomes were assessed across three complementary dimensions: (1) safety (medical adverse events, safety-related technical incidents, near-falls); (2) techno-functional usability (donning/doffing performance, assistance levels, cumulative walking exposure); and (3) acceptability (patient-reported comfort and perceived safety using session-based visual analogue scales). Physiological responses were evaluated using exoskeleton-assisted 6-minute walk tests. RESULTS: Thirteen participants were enrolled; eleven completed the full protocol. One serious adverse event occurred, a tibial plateau fracture in a participant with severe osteoporosis (hip T-score - 3.8), leading to study withdrawal. No other serious medical adverse events were observed. Across 651 sessions, four near-fall events were recorded (0.61% of sessions and 0.16% per 10 m walked). Minor adverse events were transient, and no symptomatic orthostatic hypotension was reported. Oxygen consumption, walking speed, and cost of transport (p > 0.05) remained stable between mid- and end-program assessments, while perceived exertion decreased significantly (p = 0.003). Donning time decreased from 790 [475-966] s during the first session to 223 [159-259] s during the final sessions, and doffing time from 242 [152-275] s to 55 [50-69] s, with familiarization plateau points observed after 14 and 18 sessions, respectively. Harness comfort improved over time, whereas perceived safety remained globally stable, except for transient decreases following fall-prone gait events or technical disengagements. CONCLUSIONS: Under supervised clinical conditions, the Atalante exoskeleton demonstrated acceptable safety and feasibility as an assistive locomotion device for individuals with complete paraplegia, enabling hands-free upright indoor walking with low metabolic demand. Severe osteoporosis emerged as a critical risk factor, supporting systematic bone densitometry and cautious exclusion criteria. These findings support the integration of self-balancing exoskeletons into compensatory rehabilitation programs and justify further studies in ecological settings to assess real-world autonomy and participation outcomes. Trial registration ClinicalTrials.gov Identifier: NCT06941896 (retrospective registration).
引用
- Pantera E, Reneaud N, Bouscavert C, et al. A multidimensional evaluation of the Atalante exoskeleton as an assistive locomotion device for individuals with complete paraplegia: a prospective longitudinal study in a controlled environment. J Neuroeng Rehabil. 2026. PMID: 42343362. doi:10.1186/s12984-026-01966-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。